mRNA lipid nanoparticle (LNP) technology presents enormous opportunities to prevent and
treat various diseases. Here, we developed a novel series of LNPs containing ionizable …

The development of lipid nanoparticle (LNP) based therapeutics for delivery of RNA has
triggered the advance of new strategies for formulation, such as high throughput …

Vaccines are the cornerstone of world health. The majority of vaccines are formulated as
injectable products, facing the drawbacks of cold chain transportation, needle-stick injuries …

Recent progress in synchrotron based X-ray scattering methods applied to colloid science is
reviewed. An important figure of merit of these techniques is that they enable in situ …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with high malignancy and
resistance to conventional treatments, resulting in a bleak prognosis. Nanoparticles offer a …

Self‐assembled lipid nanoparticles (LNPs), serving as essential nanocarriers in recent
COVID‐19 mRNA vaccines, provide a stable and versatile platform for delivering a wide …

Lipid-based lyotropic liquid crystalline nanoparticles (LCNPs) face stability challenges in
biological fluids during clinical translation. Ionic Liquids (ILs) have emerged as effective …

Lipid nanoparticles (LNPs) have proven to be promising delivery vehicles for RNA-based
vaccines and therapeutics, particularly in LNP formulations containing ionizable cationic …

Lipid nanoparticles (LNPs) produced by antisolvent precipitation (ASP) are used in
formulations for mRNA drug delivery. The mesoscopic structure of such complex …

Macrophages are unique immune cells attracting growing attention as a potential candidate
for cell‐based therapy for infectious diseases and cancer. Strategies that can reprogramme …